esaxerenone   Click here for help

GtoPdb Ligand ID: 9894

Synonyms: CS-3150 | XL-550
Approved drug PDB Ligand
esaxerenone is an approved drug (Japan (2019))
Compound class: Synthetic organic
Comment: Selective antagonist of the mineralocorticoid receptor that has progressed to clinical trials in a number of indications [1].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 5
Hydrogen bond donors 2
Rotatable bonds 8
Topological polar surface area 96.78
Molecular weight 466.12
XLogP 3.38
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES OCCn1cc(c(c1c1ccccc1C(F)(F)F)C)C(=O)Nc1ccc(cc1)S(=O)(=O)C
Isomeric SMILES OCCn1cc(c(c1c1ccccc1C(F)(F)F)C)C(=O)Nc1ccc(cc1)S(=O)(=O)C
InChI InChI=1S/C22H21F3N2O4S/c1-14-18(21(29)26-15-7-9-16(10-8-15)32(2,30)31)13-27(11-12-28)20(14)17-5-3-4-6-19(17)22(23,24)25/h3-10,13,28H,11-12H2,1-2H3,(H,26,29)
InChI Key NOSNHVJANRODGR-UHFFFAOYSA-N
No information available.
Summary of Clinical Use Click here for help
Esaxerenone was approved in Japan to treat hypertension (in 2019). It remains under clinical evaluations in other jurisdictions, in conditions that include hypertension, essential hypertension, hyperaldosteronism, diabetic nephropathies and NASH.